Published in J Pharmacol Exp Ther on November 01, 1990
Equipotent inhibition by R(-)-, S(+)- and racemic ibuprofen of human polymorphonuclear cell function in vitro. Br J Clin Pharmacol (1993) 0.84
Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research. Prog Lipid Res (2015) 0.84
Drug Induced Steatohepatitis: An Uncommon Culprit of a Common Disease. Biomed Res Int (2015) 0.80
The Importance of Patient-Specific Factors for Hepatic Drug Response and Toxicity. Int J Mol Sci (2016) 0.79
Selective inhibition of fatty acid oxidation in colonocytes by ibuprofen: a cause of colitis? Gut (1995) 0.79
Drug-induced steatohepatitis. Clin Liver Dis (2013) 0.78
Chirality and nonsteroidal anti-inflammatory drugs. Drugs (1996) 0.76
Organ-specific disease provoked by systemic autoimmunity. Cell (1996) 6.44
From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity (1999) 5.38
Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature (2000) 4.53
Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy. Ann Intern Med (1997) 3.49
MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res (1997) 3.38
Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. N Engl J Med (2001) 2.95
Human immunodeficiency virus type 1 envelope gene structure and diversity in vivo and after cocultivation in vitro. J Virol (1992) 2.88
Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology (1999) 2.63
Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology (1995) 2.54
Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther (2011) 2.50
Recombinant human alpha-interferon in patients with chronic non-A, non-B hepatitis: a multicenter randomized controlled trial from France. Hepatology (1991) 2.38
Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol (1999) 2.33
Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French cases. Hepatology (2000) 2.21
Diffuse inflammatory lesions in patients treated with interferon alfa and ribavirin for hepatitis C: a series of 20 patients. Br J Dermatol (2002) 2.15
Fatal exacerbation of chronic hepatitis B induced by recombinant alpha-interferon. Lancet (1991) 2.14
Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med (2000) 2.08
Genetic influences on the end-stage effector phase of arthritis. J Exp Med (2001) 1.99
An alcoholic binge causes massive degradation of hepatic mitochondrial DNA in mice. Gastroenterology (1999) 1.92
Variable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause? Gut (2001) 1.88
The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study. Hepatology (2001) 1.87
Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death. Gut (2000) 1.84
Doppler study of mesenteric, hepatic, and portal circulation in alcoholic cirrhosis: relationship between quantitative Doppler measurements and the severity of portal hypertension and hepatic failure. Hepatology (1998) 1.81
Will relaxing safe current limits for electromedical equipment increase hazards to patients? Circulation (1994) 1.79
Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol Ther (1995) 1.78
Epithelioid hemangioendothelioma, multiple focal nodular hyperplasias, and cavernous hemangiomas of the liver. Arch Pathol Lab Med (1999) 1.71
Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C. Hepatology (1998) 1.69
Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients. Gut (2002) 1.68
Straight hair associated with interferon-alfa plus ribavirin in hepatitis C infection. Br J Dermatol (2002) 1.66
Alcoholic cirrhosis is a good indication for liver transplantation, even for cases of recidivism. Gut (1999) 1.66
Value of endoscopic ultrasound guided fine needle aspiration biopsy in the diagnosis of solid pancreatic masses. Gut (2000) 1.63
Liver adenomatosis. An entity distinct from liver adenoma? Gastroenterology (1985) 1.62
Expression of vascular endothelial growth factor in digestive neuroendocrine tumours. Histopathology (1998) 1.61
Diterpenoids from germander, an herbal medicine, induce apoptosis in isolated rat hepatocytes. Gastroenterology (1997) 1.61
Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology (1986) 1.59
Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes. Gastroenterology (1998) 1.58
Diagnostic and therapeutic aspects of endoscopic retrograde cholangiography in papillomatosis of the bile ducts: analysis of five cases. Gastrointest Endosc (1997) 1.54
PML nuclear bodies are general targets for inflammation and cell proliferation. Cancer Res (1995) 1.54
Expression of complement-regulatory proteins in normal and UW-preserved human liver. Gastroenterology (1994) 1.54
Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. Hepatology (2001) 1.51
Hepatitis after intravenous buprenorphine misuse in heroin addicts. J Hepatol (2001) 1.51
Purification and characterization of six cytochrome P-450 isozymes from human liver microsomes. Biochemistry (1983) 1.51
Randomized controlled trial of adenine arabinoside 5'-monophosphate in chronic active hepatitis B: comparison of the efficacy in heterosexual and homosexual patients. Hepatology (1989) 1.50
Peliosis hepatis in recipients of renal transplants. Gut (1978) 1.48
Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice. J Hepatol (1996) 1.46
Chronic hepatitis in kidney allograft recipients. Lancet (1990) 1.45
Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-alpha in patients with chronic hepatitis C. Ann Intern Med (1997) 1.44
Mechanisms for experimental buprenorphine hepatotoxicity: major role of mitochondrial dysfunction versus metabolic activation. J Hepatol (2001) 1.44
Transvenous liver biopsy: an experience based on 1000 hepatic tissue samplings with this procedure. Gastroenterology (1982) 1.43
The ins and outs of mitochondrial dysfunction in NASH. Diabetes Metab (2004) 1.43
[Needle-tract seeding after ultrasound-guided puncture of hepatocellular carcinoma. A study of 150 patients]. Gastroenterol Clin Biol (1999) 1.41
[Severe ischemic hepatitis after taking cibenzoline]. Ann Gastroenterol Hepatol (Paris) (1991) 1.40
Liver in obesity. Gut (1985) 1.39
Exacerbation of multiple sclerosis after the administration of recombinant human interferon alfa. JAMA (1989) 1.38
Mitochondria in steatohepatitis. Semin Liver Dis (2001) 1.35
Concomitant or consecutive infection with Coxiella burnetii and tickborne diseases. Clin Infect Dis (2004) 1.30
Purification and characterization of the rat liver microsomal cytochrome P-450 involved in the 4-hydroxylation of debrisoquine, a prototype for genetic variation in oxidative drug metabolism. Biochemistry (1984) 1.29
Nodular regenerative hyperplasia of the liver. Report of six cases and review of the literature. Gastroenterology (1978) 1.29
A new hepadnavirus endemic in arctic ground squirrels in Alaska. J Virol (1996) 1.26
Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. Gastroenterology (1996) 1.26
Mechanism for the protective effects of silymarin against carbon tetrachloride-induced lipid peroxidation and hepatotoxicity in mice. Evidence that silymarin acts both as an inhibitor of metabolic activation and as a chain-breaking antioxidant. Biochem Pharmacol (1990) 1.25
Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role. Clin Res Hepatol Gastroenterol (2011) 1.25
Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression. Br J Cancer (2005) 1.24
Auxiliary liver transplantation: regeneration of the native liver and outcome in 30 patients with fulminant hepatic failure--a multicenter European study. Hepatology (1996) 1.23
In vitro infection of adult normal human hepatocytes in primary culture by hepatitis C virus. J Gen Virol (1998) 1.23
Rapid superselective high-dose cisplatin infusion for advanced head and neck malignancies. Head Neck (1992) 1.22
Drug-induced prolonged cholestasis in adults: a histological semiquantitative study demonstrating progressive ductopenia. Hepatology (1992) 1.22
Acute ethanol administration oxidatively damages and depletes mitochondrial dna in mouse liver, brain, heart, and skeletal muscles: protective effects of antioxidants. J Pharmacol Exp Ther (2001) 1.19
[Hepatitis caused by non-steroidal anti-inflammatory agents. A cooperative evaluation of regional centers of drug surveillance for 1985]. Therapie (1988) 1.19
Impaired mitochondrial function in microvesicular steatosis. Effects of drugs, ethanol, hormones and cytokines. J Hepatol (1997) 1.18
Close correlation between beta-catenin gene alterations and nuclear accumulation of the protein in human hepatocellular carcinomas. Oncogene (1999) 1.18
Polymorphism of dextromethorphan oxidation in a French population. Br J Clin Pharmacol (1987) 1.17
Portal hypertension in systemic mastocytosis. Gastroenterology (1978) 1.17
Hepatotoxicity due to mitochondrial dysfunction. Cell Biol Toxicol (1999) 1.16
Clinical course of spontaneous reactivation of hepatitis B virus infection in patients with chronic hepatitis B. Hepatology (1990) 1.16
Multiple hepatic mitochondrial DNA deletions suggest premature oxidative aging in alcoholic patients. J Hepatol (1997) 1.16
Hepatotoxicity of antitubercular treatments. Rationale for monitoring liver status. Drug Saf (1996) 1.16
Idiopathic portal hypertension (perisinusoidal fibrosis) after renal transplantation. Gut (1979) 1.15
[Hepatitis caused by diclofenac]. Gastroenterol Clin Biol (1983) 1.15
Acute and chronic drug-induced hepatitis. Baillieres Clin Gastroenterol (1988) 1.15
Hepatitis B virus and hepatitis B-related viral infection in renal transplant recipients. A prospective study of 90 patients. Gastroenterology (1988) 1.15